PROCEPT BioRobotics Corporation Comprehensive Income
PROCEPT BioRobotics Corporation (PRCT) reported Comprehensive Income of -$26.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-05
- PROCEPT BioRobotics Corporation comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$26.82M.
- PROCEPT BioRobotics Corporation comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$31.69M.
- PROCEPT BioRobotics Corporation comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$29.85M.
- PROCEPT BioRobotics Corporation comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$21.23M.
- PROCEPT BioRobotics Corporation comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$95.65M.
- PROCEPT BioRobotics Corporation comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$91.38M.
- PROCEPT BioRobotics Corporation comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$105.81M.
- PROCEPT BioRobotics Corporation comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$87.11M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$26.82M 10-Q · filed 2026-08-05 | -$58.51M 10-Q · filed 2026-08-05 | -$88.36M derived: sum of 3 quarters · filed 2026-08-05 | -$109.59M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$31.69M 10-Q · filed 2026-04-30 | -$61.54M derived: sum of 2 quarters · filed 2026-04-30 | -$82.77M derived: sum of 3 quarters · filed 2026-04-30 | -$102.71M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$29.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$51.08M derived: sum of 2 quarters · filed 2026-02-26 | -$71.02M derived: sum of 3 quarters · filed 2026-08-05 | -$95.65M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$21.23M 10-Q · filed 2025-11-05 | -$41.17M derived: sum of 2 quarters · filed 2026-08-05 | -$65.80M 10-Q · filed 2025-11-05 | -$84.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$19.95M 10-Q · filed 2026-08-05 | -$44.57M 10-Q · filed 2026-08-05 | -$63.30M derived: sum of 3 quarters · filed 2026-08-05 | -$84.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$24.63M 10-Q · filed 2026-04-30 | -$43.35M derived: sum of 2 quarters · filed 2026-04-30 | -$64.34M derived: sum of 3 quarters · filed 2026-04-30 | -$90.08M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$18.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$39.72M derived: sum of 2 quarters · filed 2026-02-26 | -$65.45M derived: sum of 3 quarters · filed 2026-02-26 | -$91.38M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$20.99M 10-Q · filed 2025-11-05 | -$46.73M derived: sum of 2 quarters · filed 2025-11-05 | -$72.66M 10-Q · filed 2025-11-05 | -$100.07M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$25.74M 10-Q · filed 2025-08-07 | -$51.67M 10-Q · filed 2025-08-07 | -$79.08M derived: sum of 3 quarters · filed 2026-02-26 | -$103.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$25.93M 10-Q · filed 2025-05-02 | -$53.34M derived: sum of 2 quarters · filed 2026-02-26 | -$77.96M derived: sum of 3 quarters · filed 2026-02-26 | -$103.27M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$27.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$52.04M derived: sum of 2 quarters · filed 2026-02-26 | -$77.34M derived: sum of 3 quarters · filed 2026-02-26 | -$105.81M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$24.62M 10-Q · filed 2024-10-28 | -$49.93M derived: sum of 2 quarters · filed 2024-10-28 | -$78.39M 10-Q · filed 2024-10-28 | -$106.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$25.31M 10-Q · filed 2024-08-02 | -$53.77M 10-Q · filed 2024-08-02 | -$82.16M derived: sum of 3 quarters · filed 2025-02-27 | -$104.59M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$28.46M 10-Q · filed 2024-05-02 | -$56.86M derived: sum of 2 quarters · filed 2025-02-27 | -$79.29M derived: sum of 3 quarters · filed 2025-02-27 | -$98.39M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$28.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$50.82M derived: sum of 2 quarters · filed 2025-02-27 | -$69.92M derived: sum of 3 quarters · filed 2025-02-27 | -$87.11M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$22.43M 10-Q · filed 2023-11-02 | -$41.53M derived: sum of 2 quarters · filed 2023-11-02 | -$58.71M 10-Q · filed 2023-11-02 | -$77.07M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$19.10M 10-Q · filed 2023-07-28 | -$36.28M 10-Q · filed 2023-07-28 | -$54.64M derived: sum of 3 quarters · filed 2024-02-28 | -$68.75M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$17.18M 10-Q · filed 2023-05-04 | -$35.55M derived: sum of 2 quarters · filed 2024-02-28 | -$49.65M derived: sum of 3 quarters · filed 2024-02-28 | -$64.24M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$18.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$32.47M derived: sum of 2 quarters · filed 2024-02-28 | -$47.05M derived: sum of 3 quarters · filed 2024-02-28 | -$59.89M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$14.11M 10-Q · filed 2022-11-04 | -$28.69M derived: sum of 2 quarters · filed 2022-11-04 | -$41.53M 10-Q · filed 2022-11-04 | -$56.83M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$14.59M 10-Q · filed 2022-08-05 | -$27.43M 10-Q · filed 2022-08-05 | -$42.73M derived: sum of 3 quarters · filed 2022-08-05 | -$54.75M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | -$12.84M 10-Q · filed 2022-05-06 | -$28.14M derived: sum of 2 quarters · filed 2022-05-06 | -$40.16M derived: sum of 3 quarters · filed 2022-05-06 | |
| 2020-12-31 | -$15.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$27.32M derived: sum of 2 quarters · filed 2022-03-22 | -$53.04M 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$12.02M 10-Q · filed 2021-11-05 | -$37.74M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |